ACRX MENU

About ACRX

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain. The company's late-stage pipeline includes ARX-04 (sufentanil sublingual tablet, 30 mcg) for the treatment of moderate-to-severe acute pain in a medically supervised setting; and Zalviso (sufentanil sublingual tablet system) for the management of moderate-to-severe acute pain in adult patients in the hospital setting.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ACRX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
IBB iShares Nasdaq Biotechnology Index Fund 7.6 B 7.57157E+09 215 215 0.03% 0.0003 1.9 M 1929920
ITOT iShares Core S&P Total U.S. Stock Market ETF 24.8 B 2.47988E+10 3,547 3547 0.0% 0 186 K 185722
IWC iShares Microcap ETF 860.9 M 8.60942E+08 1,382 1382 0.05% 0.0005 454 K 453586
IWM iShares Russell 2000 ETF 47.7 B 4.77409E+10 1,979 1979 0.01% 0.0001 4.2 M 4227220
IWN iShares Russell 2000 Value ETF 9.8 B 9.78864E+09 1,379 1379 0.01% 0.0001 1.2 M 1172900
IWO iShares Russell 2000 Growth ETF 9.7 B 9.65541E+09 1,153 1153 0.01% 0.0001 559 K 559461
IWV iShares Russell 3000 ETF 10.0 B 1.00185E+10 2,882 2882 0.0% 0 88 K 87537
VTWG Vanguard Russell 2000 Growth ETF 302.7 M 3.027E+08 1,177 1177 0.01% 5.08655E-05 16 K 15734
TILT FlexShares Mornigstar US Market Factors Tilt Index Fund ETF 1.5 B 1.48129E+09 2,223 2223 0.0% 8E-06 12 K 11737
BIB ProShares Ultra Nasdaq Biotechnology 197.0 M 1.96992E+08 226 226 0.01% 8.34964E-05 37 K 36863
UBIO Proshares UltraPro Nasdaq Biotechnology 27.7 M 2.77497E+07 221 221 0.0% 4.63685E-05 4 K 4336
URTY ProShares UltraPro Russell2000 106.6 M 1.06613E+08 1,991 1991 0.0% 2.22398E-05 8 K 7565
UWM ProShares Ultra Russell2000 206.3 M 2.06278E+08 1,990 1990 0.0% 3.18374E-05 14 K 14454